The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 20, 2021

Filed:

Aug. 29, 2019
Applicant:

Xenon Pharmaceuticals Inc., Burnaby, CA;

Inventors:

Jean-Christophe Andrez, Vancouver, CA;

Kristen Nicole Burford, Burnaby, CA;

Christoph Martin Dehnhardt, Burnaby, CA;

Thilo Focken, Burnaby, CA;

Michael Edward Grimwood, North Vancouver, CA;

Qi Jia, Burnaby, CA;

Verner Alexander Lofstrand, Burnaby, CA;

Shaoyi Sun, Coquitlam, CA;

Steven Sigmund Wesolowski, Natick, MA (US);

Michael Scott Wilson, Burnaby, CA;

Alla Yurevna Zenova, Vancouver, CA;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 471/04 (2006.01); A61K 31/437 (2006.01); C07D 417/14 (2006.01); C07D 401/12 (2006.01); C07D 401/14 (2006.01); C07D 409/12 (2006.01); C07D 413/12 (2006.01); C07D 417/12 (2006.01); C07D 487/08 (2006.01);
U.S. Cl.
CPC ...
C07D 417/14 (2013.01); C07D 401/12 (2013.01); C07D 401/14 (2013.01); C07D 409/12 (2013.01); C07D 413/12 (2013.01); C07D 417/12 (2013.01); C07D 471/04 (2013.01); C07D 487/08 (2013.01);
Abstract

This invention is directed to benzenesulfonamide compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment of diseases or conditions associated with voltage-gated sodium channels, such as epilepsy and/or epileptic seizure disorders.


Find Patent Forward Citations

Loading…